Norovirus Vaccine
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 21
Special Issue Editors
Interests: polyomavirus; norovirus; astrovirus; viral entry
Interests: gastroenteritis virus; norovirus; rotavirus; sapovirus; astorovirus
Special Issue Information
Dear Colleagues,
Given the current surge in norovirus cases—one of the leading causes of acute gastroenteritis worldwide—there is an urgent need for effective vaccines to alleviate the significant social and economic burden of outbreaks. With multiple norovirus vaccines in progress, continued research is essential to accelerate vaccine development and maximize their potential public health impact.
We are pleased to invite you and your colleagues to submit a contribution to this Special Issue, “Norovirus Vaccine”, in which leading experts will describe their work, ideas, and findings. We will cover the major continuing advances in the development of vaccines and immunotherapy treatment for noroviruses, including the following topics: the design and characterization of potential vaccine antigens and candidates, the development of monoclonal antibodies, the testing of vaccine platforms and adjuvants in animals and humans, antiviral immunity, and the relationship between immune responses and viral pathogenesis. Other related topics will also be considered, and these could be related to investigations with which to understand the challenges in current vaccines, broadly neutralizing antibodies, structural function analysis, and theoretical studies on vaccine design.
In this Special Issue, original research articles and reviews are welcome. We look forward to receiving your contributions.
Prof. Dr. Akira Nakanishi
Prof. Dr. Kazuhiko Katayama
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- norovirus
- gastroenteritis
- vaccine
- VLP-based
- multivalent
- virus-specific IgA
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
